Kevin Tan
Director of Finance/CFO chez SOLID BIOSCIENCES INC.
Fortune : 123 983 $ au 31/03/2024
Profil
Kevin Tan is currently the Chief Financial Officer at Solid Biosciences, Inc. He previously worked as Treasurer at Sarepta Therapeutics, Inc. from 2018 to 2021 and as Chief Financial & Accounting Officer at Selecta Biosciences, Inc. from 2021 to 2022.
Prior to his roles in the biotech industry, he was a Senior Portfolio Manager at CPP Investments Ltd.
Mr. Tan received his undergraduate degree from Queen's University, his graduate degree from Princeton University, and his MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLID BIOSCIENCES INC.
0,02% | 13/02/2024 | 9 308 ( 0,02% ) | 123 983 $ | 31/03/2024 |
Postes actifs de Kevin Tan
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director of Finance/CFO | 09/01/2023 |
Anciens postes connus de Kevin Tan
| Sociétés | Poste | Fin |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 28/11/2022 |
| SAREPTA THERAPEUTICS, INC. | Treasurer | 01/09/2021 |
CPP Investments Ltd.
 CPP Investments Ltd. Investment ManagersFinance Part of Helical Plc, CPP Investments Ltd. is a British company that provides investment management services. The private company is based in London, UK. CPP Investments was founded in 1988. | Corporate Officer/Principal | - |
Formation de Kevin Tan
| Queen's University | Undergraduate Degree |
| Princeton University | Graduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| SOLID BIOSCIENCES INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
CPP Investments Ltd.
CPP Investments Ltd. Investment ManagersFinance Part of Helical Plc, CPP Investments Ltd. is a British company that provides investment management services. The private company is based in London, UK. CPP Investments was founded in 1988. | Finance |
